Sperling Prostate Center

12/03/2025

What happens when a doctor finds out he has prostate cancer, gets treated, then deals with side effects? Read the true first-person account here.

A physiatrist diagnosed with prostate cancer shares his story of recovery, arguing that pelvic floor rehabilitation must become standard care to address incontinence and restore patient dignity. Learn more.

11/27/2025

A large British study is testing a new AI-powered “one day diagnosis” so men with a suspicious MRI can be immediately prioritized for further diagnostics.

AI will be used to interpret MRI scans for men suspected of having the disease, helping to spot lesions within minutes

11/20/2025

Did you know? An elevated PSA doesn’t automatically mean cancer. mpMRI can help clarify what’s really happening before decisions about biopsy or treatment are made.

For decades, prostate cancer screening relied almost entirely on the PSA blood test — often followed by a random biopsy if the level was high. That approach saved lives but also led to unnecessary biopsies and missed aggressive cancers. Today, that’s changing dramatically thanks to one major adv...

11/13/2025

💊 The FDA has fast-tracked a new oral drug that may offer improved cancer control for patients with metastatic prostate cancer that no longer responds to hormones.

If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.

11/06/2025

Could something as simple as a daily multivitamin help lower the chances of prostate cancer returning? New research points to a potential benefit – especially for men with more aggressive cases.

A recent study brings evidence to light that multivitamin use after prostate cancer treatment may lower the chances of recurrence.

10/29/2025

Urine spermine is gaining attention as a noninvasive biomarker for prostate cancer. Studies show that when combined with PSA and MRI, it can accurately identify high-grade disease while reducing unnecessary biopsies.

Recent evidence suggests that a compound called spermine, which can be measured in a urine test, predicts high grade prostate cancer and also identifies which men can avoid a biopsy.

10/23/2025

Not all prostate biopsies are created equal ❌ In-bore MRI guidance offers a safer, more accurate way to detect significant prostate cancer, minimizing risks while maximizing results.

Comparison studies show that real time in-bore MRI guided biopsy is superior in diagnostic accuracy over fusion or cognitive guidance.

10/15/2025

🔎 Active surveillance helps men avoid overtreatment, but how often should tests and scans be done? New research suggests genetics may hold the answer.

A polygenic risk score may assist in matching Active Surveillance to each patient’s need.

10/08/2025

Should Gleason 3+3 prostate cancer keep the name ‘cancer’? Experts weigh in on whether this low-risk condition deserves a new label.

What’s in a name? Gleason 3+3 is the subject of a growing debate: indolent condition or true cancer? Here’s what patients need to know.

10/01/2025

📊 The numbers are in — and they’re hard to ignore. A new study of over 500,000 men shows a 15% higher risk of death when PSA screening is skipped.

Veterans Administration facilities that practice greater rates of annual PSA screening have lower rates of men being diagnosed with metastatic prostate cancer.

09/18/2025

Can what you eat help manage prostate cancer? This study out of the University of Texas says yes. Discover how the Mediterranean diet could help men on Active Surveillance delay the need for treatment and protect quality of life.

High adherence to the Mediterranean diet is protective against prostate cancer progression during Active Surveillance.

09/10/2025

Did you know? Poor dietary habits may increase your risk of prostate cancer because of the link between your gut bacteria (microbiome) and your body.

Read the research 👉 https://pubmed.ncbi.nlm.nih.gov/40374457/